Tim Coleman is the founder of Immunomic Therapeutics. Immunomic Therapeutics has raised $61M in total funding. Latest round: Growth.
Tim Coleman joined Immunomic Therapeutics in 2015 and was promoted to Senior Vice President, Operations and General Manager in October 2020. In this role, he expanded his responsibilities to include operations, process development, facilities, and IT, and is a contributing member of the executive leadership team. He played a key role in managing manufacturing activities for ITI's lead candidates with strategic partners.
Full founder directory · Investor directory · Company funding database · Fundraising library